The genetics of hypertension

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Nature Reviews Nephrology

• Publication date

  2025-11-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41581-025-01020-6PMID 41219524
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.

  2026cited by this paper
• Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline.

  2025cited by this paper
• 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2025cited by this paper
• Baxdrostat Efficacy and Safety in Uncontrolled and Resistant Hypertension

  2025cited by this paper
• GWAS for Defining the Etiology of Hypertension: Have They Delivered?

  2025cited by this paper
• Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits

  2024influential reference
• 2024 ESC Guidelines for the management of elevated blood pressure and hypertension.

  2024cited by this paper
• Just a SNP away: The future of in vivo massively parallel reporter assay

  2024influential reference
• Genetic imputation of kidney transcriptome, proteome and multi-omics illuminates new blood pressure and hypertension targets

  2024cited by this paper
• Familial Hyperaldosteronism: an ENDO ERN Clinical Practice Guideline.

  2024influential reference
• 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension.

  2024cited by this paper
• Exome sequencing implicates ancestry-related Mendelian variation at SYNE1 in childhood-onset essential hypertension

  2024cited by this paper
• Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension

  2023cited by this paper
• Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism

  2023cited by this paper
• Targetable NOTCH1 rearrangements in reninoma

  2023cited by this paper
• The gut microbiome and hypertension

  2023cited by this paper
• A systems biology approach identifies the role of dysregulated PRDM6 in the development of hypertension

  2023cited by this paper
• Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production

  2023influential reference
• Polygenic prediction of preeclampsia and gestational hypertension

  2023cited by this paper
• Systematic characterization of regulatory variants of blood pressure genes

  2023cited by this paper
• Impact of environmental factors on hypertension and associated cardiovascular disease.

  2023cited by this paper
• Cushing Syndrome: A Review.

  2023cited by this paper
• Isradipine therapy in Cacna1dIle772Met/+ mice ameliorates primary aldosteronism and neurologic abnormalities

  2023cited by this paper
• Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes

  2022influential reference
• Overexpression of notch signaling in renin cells leads to a polycystic kidney phenotype.

  2022cited by this paper
• Apparent mineralocorticoid excess: comprehensive overview of molecular genetics

  2022cited by this paper
• A Single Nucleotide Polymorphism in SH2B3/LNK Promotes Hypertension Development and Renal Damage

  2022cited by this paper
• Integration of artificial intelligence and plasma steroidomics with laboratory information management systems: application to primary aldosteronism

  2022cited by this paper
• Insights From a Large-Scale Whole-Genome Sequencing Study of Systolic Blood Pressure, Diastolic Blood Pressure, and Hypertension

  2022cited by this paper
• Genetics of Primary Aldosteronism

  2022cited by this paper
• A Novel Homozygous KLHL3 Mutation as a Cause of Autosomal Recessive Pseudohypoaldosteronism Type II Diagnosed Late in Life

  2022cited by this paper
• Enhanced Ca 2+ signaling, mild primary aldosteronism, and hypertension in a familial hyperaldosteronism mouse model ( Cacna1h M1560V/+ )

  2021cited by this paper
• Enhanced Ca2+ signaling, mild primary aldosteronism, and hypertension in a familial hyperaldosteronism mouse model (Cacna1hM1560V/+)

  2021cited by this paper
• Exome sequencing and analysis of 454,787 UK Biobank participants

  2021cited by this paper
• Rare variant contribution to human disease in 281,104 UK Biobank exomes

  2021cited by this paper
• Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants.

  2021influential reference
• Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause

  2021cited by this paper
• Uncovering genetic mechanisms of hypertension through multi-omic analysis of the kidney

  2021influential reference
• A practical view of fine-mapping and gene prioritization in the post-genome-wide association era

  2020cited by this paper
• De novo CACAN1D Ca2+ channelopathies: clinical phenotypes and molecular mechanism

  2020cited by this paper
• International histopathology consensus for unilateral primary aldosteronism.

  2020cited by this paper
• Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review.

  2020cited by this paper
• Somatic SDHA mutations in paragangliomas in siblings

  2020cited by this paper
• Genomics of hypertension: the road to precision medicine

  2020influential reference
• Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

  2020cited by this paper
• Phosphodiesterase 3A and Arterial Hypertension

  2020cited by this paper
• Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on endocrine hypertension of the European society of hypertension.

  2020cited by this paper
• The WNK signaling pathway and salt-sensitive hypertension

  2020cited by this paper
• Somatic CACNA1H Mutation As a Cause of Aldosterone-Producing Adenoma

  2020cited by this paper
• Elevated aldosterone and blood pressure in a mouse model of familial hyperaldosteronism with ClC-2 mutation

  2019cited by this paper
• Classic and Nonclassic Apparent Mineralocorticoid Excess Syndrome.

  2019cited by this paper
• Recurrent Germline DLST Mutations in Individuals with Multiple Pheochromocytomas and Paragangliomas.

  2019cited by this paper
• Missing heritability of complex diseases: case solved?

  2019cited by this paper
• Case report: A somatic mutation in CLCN2 identified in a sporadic aldosterone producing adenoma.

  2019cited by this paper
• Cellular and Genetic Causes of Idiopathic Hyperaldosteronism

  2018cited by this paper
• Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits

  2018cited by this paper
• Metabolome-guided genomics to identify mutations in isocitrate dehydrogenase, fumarate hydratase and succinate dehydrogenase genes in pheochromocytoma and paraganglioma

  2018cited by this paper
• Identification of recurrent USP48 and BRAF mutations in Cushing’s disease

  2018cited by this paper
• Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas.

  2018cited by this paper
• Three Reportedly Unrelated Families With Liddle Syndrome Inherited From a Common Ancestor

  2018cited by this paper
• Genetics of Cushing's Syndrome.

  2018cited by this paper
• A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism

  2018cited by this paper
• Identification of pathogenic YY1AP1 splice variants in siblings with Grange syndrome by whole exome sequencing

  2018cited by this paper
• Trans-ethnic association study of blood pressure determinants in over 750,000 individuals

  2018influential reference
• Phenotype-specific enrichment of Mendelian disorder genes near GWAS regions across 62 complex traits

  2018cited by this paper
• Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing’s disease

  2017cited by this paper
• Activating FGFR1 Mutations in Sporadic Pheochromocytomas

  2017cited by this paper
• Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations With Midlife Blood Pressure Levels and Cardiovascular Events

  2017cited by this paper
• Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic.

  2017cited by this paper
• A Genetic Variant Associated with Five Vascular Diseases Is a Distal Regulator of Endothelin-1 Gene Expression.

  2017cited by this paper
• A Missense Mutation in the Extracellular Domain of αENaC Causes Liddle Syndrome.

  2017cited by this paper
• Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.

  2017cited by this paper
• Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015

  2017cited by this paper
• CLCN2 Chloride Channel Mutations in Familial Hyperaldosteronism Type II

  2017cited by this paper
• Loss-of-Function Mutations in YY1AP1 Lead to Grange Syndrome and a Fibromuscular Dysplasia-Like Vascular Disease.

  2017cited by this paper
• Concepts, estimation and interpretation of SNP-based heritability

  2017cited by this paper
• The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline.

  2016influential reference
• Polyhydramnios, Transient Antenatal Bartter's Syndrome, and MAGED2 Mutations.

  2016cited by this paper
• Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.

  2016cited by this paper
• Differential expression and DNA methylation of angiotensin type 1A receptors in vascular tissues during genetic hypertension development

  2015cited by this paper
• Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

  2015cited by this paper
• Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands

  2015cited by this paper
• Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

  2015cited by this paper
• Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation

  2015cited by this paper
• Genetic and molecular aspects of hypertension.

  2015cited by this paper
• Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism

  2015cited by this paper
• The support of human genetic evidence for approved drug indications

  2015cited by this paper
• PDE3A mutations cause autosomal dominant hypertension with brachydactyly

  2015cited by this paper
• Whole‐exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene

  2015cited by this paper
• Peripheral and central effects of circulating catecholamines.

  2014cited by this paper
• Validation of Uromodulin as a Candidate Gene for Human Essential Hypertension

  2014cited by this paper
• Mutations in the deubiquitinase gene USP8 cause Cushing's disease

  2014cited by this paper
• Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.

  2014cited by this paper
• Whole exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas

  2014cited by this paper
• Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism

  2013cited by this paper
• Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.

  2013cited by this paper
• Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension

  2013cited by this paper
• Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension

  2013cited by this paper
• Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations

  2013cited by this paper
• Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.

  2013cited by this paper

• Sequentially activated fluorescent probes based on a purine scaffold: enabling precise spatiotemporal monitoring of H2O2 and tyrosine hydroxylase in the brainstem NTS during spontaneous hypertension.

  2026cites this paper